Compare Immunefi (IMU) vs Enzyme (MLN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Immunefi vs Enzyme — how do they compare? Immunefi trades at Rp24.67 (market cap Rp27,03M, Rp39,91M 24h volume), while Enzyme trades at Rp30,212 (market cap Rp134,13M, Rp104,56M 24h volume). The key difference: Enzyme is far larger — about 5× Immunefi's market cap, and Immunefi's supply is capped (873,4M / 10B IMU (9%)) while Enzyme's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold Immunefi for 5 Days and Enzyme for 28 Days on average.
| IMU | MLN | |
|---|---|---|
Market Cap | Rp27,03M | Rp134,13M |
Volume (24h) | Rp39,91M | Rp104,56M |
Circulating Supply | 873,4M / 10B IMU (9%) | 3,3M MLN |
Typical Hold Time | 5 Days | 28 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Immunefi (IMU) currently trades with a market cap of Rp27.03M and a circulating supply of 873.4 million tokens (9% of max supply). The asset shows limited market activity with a short average hold time of 5 days, indicating potential speculative trading patterns. Recent coverage appears to confuse the token with a corporate entity, requiring careful verification of crypto-specific metrics.
Outlook remains cautious due to low circulation rate and potential identity confusion. Key opportunity lies in proper crypto ecosystem positioning, while major risks include liquidity constraints and market misidentification. Investors should verify on-chain metrics and exchange listings before considering exposure.
Enzyme (MLN) currently holds a market capitalization of Rp134.13 million with a circulating supply of 3.3 million tokens. The asset shows moderate market activity with a hold time of 28 days indicating average investor retention. Recent market data suggests stable trading patterns within the decentralized finance ecosystem, though specific price action requires current exchange verification.
Outlook remains cautiously neutral given limited recent protocol updates. Key opportunities include potential DeFi ecosystem growth integration, while risks center on typical crypto volatility and regulatory uncertainty. Investors should monitor on-chain activity and exchange liquidity for clearer directional signals.
About Immunefi
Immunefi is a security-focused ecosystem token designed to reward contributions to blockchain safety. It aligns protocols, researchers, and communities through bug bounties, staking, and governance incentives. The ecosystem also integrates AI to enhance threat detection and scale protection as the on-chain economy grows.
Read more on IMU →About Enzyme
Enzyme is an easy-to-use on-chain asset management system that enables access to digital assets and DeFi from one simple, unified app. It provides a front-to-back execution and order management system, which provides fully automated reporting, risk management, administration, governance and operations.
Read more on MLN →
